Cambridge Cognition – An excellent year for the company (Interview)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk to discuss preliminary results for 2020. Matthew talks us through the highlights, explains how the company performed during the pandemic, where sales orders across the portfolio came from, progress with Neurovocalix and the outlook for the company.

Cambridge Cognition Holdings is a world leading neuroscience technology company committed to enhancing global research, accelerating treatment development and improving patient outcomes in conditions affecting brain health by optimising the assessment of cognition.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition growth in revenue of 50% to £4.5 million

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a positive trading update for the six months ended 30 June 2021. The Company enjoyed a strong performance in the first half

Cambridge Cognition Holdings

Cambridge Cognition completes spin-out of Monument Therapeutics

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the completion of the spin-out of Monument Therapeutics Limited, a drug development company applying digital phenotyping to central nervous system disorders.

Cambridge Cognition Holdings

Cambridge Cognition secures new £2.2 million contract

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has been selected as the cognitive assessment partner for a large at-home study.  The contract is valued at £2.2 million with revenue expected

Cambridge Cognition Holdings

Cambridge Cognition AGM to be held on 27 May 2021

Cambridge Cognition Holdings plc (LON:COG) which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2020 and the Notice of the Annual General Meeting